Back to Trades
Total Value
$415.3K
Net $415.3K sold
Filing Date
Feb 23, 2026
1 transaction
Sales
$415.3K
1 transaction
Trade Summary
On Feb 20, 2026, Mutz Christopher, HEAD OF RARE DISEASE, sold $415.3K of ANI PHARMACEUTICALS INC (ANIP) across 1 transaction. The filing covers Common Stock and reflects net selling of $415.3K. Reported prices ranged from $78.02. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- ANI PHARMACEUTICALS INC
- Ticker Symbol
- ANIP
- CIK
- 0001023024
Insider Information
- Name
- Mutz Christopher
- Role
- HEAD OF RARE DISEASE
- Location
- BAUDETTE, MN
Filing Details
- Filing Date
- Feb 23, 2026
- Transaction Date
- Feb 20, 2026
- Accession Number
- 0001846487-26-000006
- Form Type
- 4
- Net Trading Amount
- -$415.3K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Feb 20, 2026 | Common Stock | 5,323 | $78.02 | Sale | $415.3K |
Want live alerts when Mutz Christopher trades again?
Download Insider Trades to track ANIP, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025.
- (F2)The shares were sold in multiple trades at prices ranging from $77.20 to $78.58. The price reported above reflects the weighted average sales price.